ROTH OTC
PharmaRoth Labs, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -90.0%
1Y: -90.0%
3Y: -99.8%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$18K
+79.4% ▲
Capital Expenditures
$0
-100.0% ▼
Free Cash Flow
-$18K
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$0
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$425K | -$291K | -$370K | -$233K | -$92K |
| Depreciation & Amort. | $2K | $460 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $130K | -$70K | $105K | $24K | $67K |
| Other Non-Cash Items | $172K | $146K | $234K | $123K | $7K |
| Operating Cash Flow | -$122K | -$215K | -$31K | -$86K | -$18K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $20K | $0 | $0 |
| Financing Cash Flow | $120K | $220K | $26K | $86K | $18K |
| Net Change in Cash | $0 | $0 | $0 | $0 | $0 |
| Cash End of Period | $623 | $6K | $824 | $762 | $1K |
| Free Cash Flow | -$122K | $0 | $0 | $0 | -$18K |